HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Erbel, R. Articles by Heusch, G. Search for Related Content PubMed PubMed Citation Articles by Erbel, R. Articles by Heusch, G.

BRIEF REVIEW

Coronary microembolization

Raimund Erbel, MD, FESC, FACC^* and Gerd Heusch, MD, FESC, FACC

^* Departments of Cardiology, University of Essen Medical School, Essen, Germany
Pathophysiology, University of Essen Medical School, Essen, Germany

Reprint requests and correspondence: Prof. Dr. Gerd Heusch, Abteilung fuer Pathophysiologie, Zentrum fuer Innere Medizin, Universitaetsklinikum Essen, Hufelandstr. 55, 45122 Essen, Germany
gerd.heusch{at}uni-essen.de

	Evidence from postmortem histology

Top Evidence from postmortem... Experimental pathophysiology of... Clinical evidence References

 
Experimental platelet and coagulation thrombi with embolization into the coronary microcirculation and subsequent microinfarction and lethal arrhythmias in the laboratory animal were described more than three decades ago (1). Subsequently, microembolization and microinfarcts were also identified at autopsy of patients with acute coronary syndromes who had died of sudden cardiac death (2,3). Atherosclerotic material, including cholesterol crystals, formed the core and source of thrombi in the microcirculation. Often there was evidence for multiple, recurrent microinfarcts secondary to atherosclerotic thrombemboli, particularly in patients with prodromal unstable angina (2,4,5). Intramyocardial thrombemboli were identified at autopsy in 15% of patients with ischemic heart disease who died out of the hospital (3).

	Experimental pathophysiology of microembolization

Top Evidence from postmortem... Experimental pathophysiology of... Clinical evidence References

 
With acute coronary arterial inflow reduction by an epicardial coronary artery stenosis, contractile function in the dependent myocardium is rapidly reduced (6). Within a few minutes, a new steady state of perfusion-contraction matching (7,8) develops in which regional myocardial function is reduced in proportion to regional myocardial blood flow, and such perfusion-contraction matching can be maintained over several hours (9) and may be the pathophysiological substrate of hibernating myocardium (10). Experimental microvascular obstruction by intracoronary injection of inert particles also induces regional contractile dysfunction, and the amount of dysfunction is proportionate to the number of injected particles (11,12). In contrast to an epicardial coronary arterial inflow reduction, baseline blood flow into the microembolized area is not reduced, but may actually be enhanced, secondary to an adenosine-related hyperemia of the myocardium surrounding the embolized microregions (11,12). Comparing an epicardial stenosis to microembolization with microspheres of 42 µm diameter at identical degrees of contractile dysfunction, we have recently demonstrated perfusion-contraction mismatch secondary to microvascular obstruction, with severe contractile dysfunction and no detectable decrease in regional blood flow (13,14). The profound contractile dysfunction could not be related to the amount of infarcted myocardium. Therefore, the mechanical disadvantage from multiple microinfarcts (Fig. 1) with multiple border zones to nonischemic myocardium appears to be greater than that of a single infarct of the same volume. Importantly, the inflammatory response to microembolization is also greater than that to inflow reduction, and inflammatory mediators may contribute to the observed contractile dysfunction.

View larger version (180K): [in this window] [in a new window]   Figure 1 Experimental microinfarct with inflammatory response in a myocardial area perfused by a small artery that has been embolized with microspheres of 42 µm in diameter. Calibration 50 µm.

	Clinical evidence

Top Evidence from postmortem... Experimental pathophysiology of... Clinical evidence References

 
New imaging techniques, in particular coronary angioscopy and intravascular ultrasound, have facilitated the detection of epicardial coronary plaque rupture and ulceration (17–21). Plaque ulceration, previously often misinterpreted as coronary aneurysm (17), is frequently found in patients with unstable and stable angina (22,23) but also occasionally in patients with a normal coronary angiogram (24). Apparently, plaque rupture and ulceration are frequent events and part of the general atherosclerotic process, as confirmed at autopsy (22,23). The material that is washed out of the plaque cannot only induce local thrombus formation in the immediate coronary arterial segment but is also dislodged into the microcirculation and can cause thrombemboli there (2). The elevations in creatine kinase (CK), troponin T and I, which are regarded as signs of micronecrosis in patients with unstable angina, may just be the consequences of such microembolization (25,26). Conversely, the efficacy of glycoprotein IIb/IIIa receptor antagonists in this scenario and in acute myocardial infarction (26) may not only reflect resolution of the thrombus overlying the ruptured epicardial plaque but also that of the thrombemboli in the microcirculation (27). Interestingly, as in the above experimental studies, inflammatory responses are also found in patients with unstable angina (28), in patients with successful percutaneous transluminal coronary angioplasty (29) and in documented cases of microembolization (30).

Not only in spontaneous plaque rupture and ulceration, but also during coronary interventions, microembolization is, in fact, induced, again leading to myocardial micronecrosis, as reflected by elevated CK and troponin (31,32) as well as by electrocardiogram changes (32) and to reduced coronary reserve, as documented with myocardial perfusion measurements (33). The incidence of such "infarctlets" is higher in those undergoing rotational atherectomy/revascularization than it is in those undergoing balloon angioplasty (34,35). Cyclic flow variations, as seen in animal experiments (15,16), are a sign predicting immediate complications after angioplasty (36). Interestingly, patients without normalization of coronary reserve after balloon angioplasty often have elevated baseline coronary flow velocity (33,37,38), reminiscent of the reactive hyperemia seen with experimental microembolization (11,12).

The best available clinical evidence for microembolization is probably from use of aspiration and filtration devices, that is, "ex iuvantibus," which can retrieve surprisingly large pieces of plaque debris and thrombotic material and prevent it from being embolized into the microcirculation (39,40).

In conclusion, putting the available pathologic "anatomic, experimental" pathophysiologic and clinical evidence together, we propose the following scheme (Fig. 2) of plaque rupture/thrombosis/microembolization, that ultimately induces the clinical consequences of arrhythmias "up to sudden death" and, most notably, contractile dysfunction.

View larger version (19K): [in this window] [in a new window]   Figure 2 Schematic presentation of epicardial plaque fissuring/plaque rupture/thrombosis inducing embolization of atherosclerotic and thrombotic material into the microcirculation, resulting in arrhythmias, micronecrosis, contractile dysfunction and reduced coronary reserve (modified from reference 41).

	Footnotes

 
The author’s studies were supported by the German Research Foundation (E 155/4-2) and the IFORES grant 107509-0 of the University of Essen Medical School, Essen, Germany.

	References

Top Evidence from postmortem... Experimental pathophysiology of... Clinical evidence References

 

1. Jorgensen L, Rowsell HC, Hovig T, et al. Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Lab Invest. 1967;17:616–644[Medline]
2. Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation. 1985;71:699–708[Abstract/Free Full Text]
3. Leach IH, Blundell JW, Rowley JM, et al. Acute ischemic lesions in death due to ischemic heart disease. An autopsy study of 333 cases of out-of-hospital death. Eur Heart J. 1995;16:1181–1185[Abstract/Free Full Text]
4. Davies MJ, Thomas AC, Knapman PA, et al. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation. 1986;73:418–427[Abstract/Free Full Text]
5. Frink RJ, Rooney PA, Trowbridge JO, et al. Coronary thrombosis and platelet/fibrin microemboli in death associated with acute myocardial infarction. Br Heart J. 1988;59:196–200[Abstract/Free Full Text]
6. Guth BD, Schulz R, Heusch G. Time course and mechanisms of contractile dysfunction during acute myocardial ischemia. Circulation. 1993;87(Suppl IV):IV35–IV42[Medline]
7. Gallagher KP, Matsuzaki M, Osakada G, et al. Effect of exercise on the relationship between myocardial blood flow and systolic wall thickening in dogs with acute coronary stenosis. Circ Res. 1983;52:716–729[Abstract/Free Full Text]
8. Ross J Jr. Myocardial perfusion-contraction matching. Circulation. 1991;83:1076–1083[Abstract/Free Full Text]
9. Matsuzaki M, Gallagher KP, Kemper WS, et al. Sustained regional dysfunction produced by prolonged coronary stenosis: gradual recovery after reperfusion. Circulation. 1983;68:170–182[Abstract/Free Full Text]
10. Heusch G. Hibernating myocardium. Physiol Rev. 1998;78:1055–1085[Abstract/Free Full Text]
11. Hori M, Inoue M, Kitakaze M, et al. Role of adenosine in hyperemic response of coronary blood flow in microcirculation. Am J Physiol. 1986;250:H509–H518[Medline]
12. Hori M, Gotoh K, Kitakaze M, et al. Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization. Circulation. 1991;84:828–840[Abstract/Free Full Text]
13. Rose J, Leischik R, Skyschally A, Erbel R, Heusch G. Regional myocardial blood flow and function after coronary microembolisation (abstr). Faseb J. 1997;11:A432
14. Dörge H, Behrends M, Neumann T, Schulz R, Erbel R, Heusch G. Perfusion-contraction mismatch with coronary microvascular obstruction (abstr). J Mol Cell Cardiol. 1999;31:A58
15. Gallagher KP, Osakada G, Kemper WS, et al. Cyclical coronary flow reductions in conscious dogs equipped with ameroid constrictors to produce severe coronary narrowing. Basic Res Cardiol. 1985;80:100–106[CrossRef][Medline]
16. Golino P, Buja M, Sheng-Kun Y, et al. Failure of nitroglycerin and diltiazem to reduce platelet-mediated vasoconstriction in dogs with coronary artery stenosis and endothelial injury: further evidence for thromboxane A2 and serotonin as mediators of coronary artery vasoconstriction in vivo. J Am Coll Cardiol. 1990;15:718–726[Abstract]
17. Zamorano J, Erbel R, Ge J, et al. Spontaneous plaque rupture visualized by intravascular ultrasound. Eur Heart J. 1994;15:131–133[Abstract/Free Full Text]
18. Ge J, Liu F, Kearney P, et al. Intravascular ultrasound approach to the diagnosis of coronary artery aneurysm. Am Heart J. 1995;130:765–771[CrossRef][Medline]
19. Ueda Y, Asakura M, Hirayama A, et al. Intracoronary morphology of culprit lesions after reperfusion in acute myocardial infarction: serial angioscopic observations. J Am Coll Cardiol. 1996;27:606–610[Abstract]
20. van Belle E, Lablanche J-M, Bauters C, et al. Coronary angioscopic findings in the infarct-related vessel within one month of acute myocardial infarction. Natural history and the effect of thrombolysis. Circulation. 1998;97:26–33[Abstract/Free Full Text]
21. Ge J, Chirillo F, Schwedtmann J, et al. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart. 1999;81:621–627[Abstract/Free Full Text]
22. Falk E. Plaque rupture with severe preexisting stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J. 1983;50:127–134[Abstract/Free Full Text]
23. Davies MJ, Thomas AC. Plaque fissuring—the cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J. 1985;53:363–373[Free Full Text]
24. Baumgart D, Liu F, Haude M, et al. Acute plaque rupture and myocardial stunning in patients with normal coronary arteriography. Lancet. 1995;346:193–194[CrossRef][Medline]
25. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146–150[Abstract]
26. Roberts R, Fromm RE. Management of acute coronary syndromes based on risk stratification by biochemical markers. Circulation. 1998;98:1831–1833[Free Full Text]
27. Mak K-H, Challapalli R, Eisenberg MJ, et al. Effect of platelet glycoprotein IIb/IIIa receptor inhibition on distal embolization during percutaneous revascularization of aortocoronary saphenous vein grafts. Am J Cardiol. 1997;80:985–988[CrossRef][Medline]
28. Ritchie ME. Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris. Circulation. 1998;98:1707–1713[Abstract/Free Full Text]
29. Tillmanns H, Neumann F-J, Tiefenbacher C, et al. Activation of neutrophils in the microvasculature of the ischemic and reperfused myocardium. Eur Heart J. 1993;14:82–86
30. Colt HG, Begg RJ, Saporito JJ, et al. Cholesterol emboli after cardiac catheterization. Medicine. 1988;67:389–400[Medline]
31. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation. 1996;94:1528–1536[Abstract/Free Full Text]
32. Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31:241–251[Abstract/Free Full Text]
33. Van Liebergen RAM, Piek JJ, Koch KT, et al. Immediate and long-term effect of balloon angioplasty or stent implantation on the absolute and relative coronary blood flow velocity reserve. Circulation. 1998;98:2133–2140[Abstract/Free Full Text]
34. Waksman R, Scott NA, Douglas JS, Mays R, Yee-Petersen J, King SB III. Distal embolization is common after directional atherectomy in coronary arteries and vein grafts (abstr). Circulation. 1993;88:I299
35. Herrmann J, Sack S, von Birgelen C, Schmermund A, Erbel R. Peri-interventionelle Myokardnekrotisierungen—Abhängigkeit von der Interventionstechnik (abstr). Z Kardiol. 1999;88(Suppl 1):188
36. Sunamura M, Di Mario C, Piek JJ, et al. Cyclic flow variations after angioplasty: a rare phenomenon predictive of immediate complications. Am Heart J. 1996;131:843–848[CrossRef][Medline]
37. Bowers TR, Stewart RE, O’Neill WW, et al. Effect of rotablator atherectomy and adjunctive balloon angioplasty on coronary blood flow. Circulation. 1997;95:1157–1164[Abstract/Free Full Text]
38. Kern MJ, Puri S, Bach RG, et al. Abnormal coronary flow velocity reserve after coronary artery stenting in patients. Role of relative coronary reserve to assess potential mechanisms. Circulation. 1999;100:2491–2498[Abstract/Free Full Text]
39. Carlino M, De Gregorio J, Di Mario C, et al. Prevention of distal embolization during saphenous vein graft lesion angioplasty. Circulation. 1999;99:3221–3223[Abstract/Free Full Text]
40. Oesterle SN, Hayase M, Baim DS, et al. An embolization containment device. Catheter Cardiovasc Intervent. 1999;47:243–250[CrossRef][Medline]
41. Erbel R, Heusch G. Coronary microembolization—its role in acute coronary syndromes and interventions. Herz. 1999;24:558–575[Medline]

This article has been cited by other articles:

				A. R. Pries, H. Habazettl, G. Ambrosio, P. R. Hansen, J. C. Kaski, V. Schachinger, H. Tillmanns, G. Vassalli, I. Tritto, M. Weis, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings Cardiovasc Res, June 25, 2008; (2008) cvn136v2. [Abstract] [Full Text] [PDF]

				M. Thielmann, M. Neuhauser, A. Marr, B. R. Jaeger, D. Wendt, B. Schuetze, M. Kamler, P. Massoudy, R. Erbel, and H. Jakob Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1143 - 1149. [Abstract] [Full Text] [PDF]

				P. Bahrmann, G. S. Werner, G. Heusch, M. Ferrari, T. C. Poerner, A. Voss, and H. R. Figulla Detection of Coronary Microembolization by Doppler Ultrasound in Patients With Stable Angina Pectoris Undergoing Elective Percutaneous Coronary Interventions Circulation, February 6, 2007; 115(5): 600 - 608. [Abstract] [Full Text] [PDF]

				A. Skyschally, P. Gres, S. Hoffmann, M. Haude, R. Erbel, R. Schulz, and G. Heusch Bidirectional Role of Tumor Necrosis Factor-{alpha} in Coronary Microembolization: Progressive Contractile Dysfunction Versus Delayed Protection Against Infarction Circ. Res., January 5, 2007; 100(1): 140 - 146. [Abstract] [Full Text] [PDF]

				R. Bugiardini, O. Manfrini, and G. M. De Ferrari Unanswered questions for management of acute coronary syndrome: risk stratification of patients with minimal disease or normal findings on coronary angiography. Arch Intern Med, July 10, 2006; 166(13): 1391 - 1395. [Abstract] [Full Text] [PDF]

				Q.-Y. Zhang, J.-B. Ge, J.-Z. Chen, J.-H. Zhu, L.-H. Zhang, C.-P. Lau, and H.-F. Tse Mast Cell Contributes to Cardiomyocyte Apoptosis after Coronary Microembolization J. Histochem. Cytochem., May 1, 2006; 54(5): 515 - 523. [Abstract] [Full Text] [PDF]

				M. Canton, A. Skyschally, R. Menabo, K. Boengler, P. Gres, R. Schulz, M. Haude, R. Erbel, F. Di Lisa, and G. Heusch Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization Eur. Heart J., April 1, 2006; 27(7): 875 - 881. [Abstract] [Full Text] [PDF]

				K. Leineweber, D. Bose, M. Vogelsang, M. Haude, R. Erbel, and G. Heusch Intense Vasoconstriction in Response to Aspirate From Stented Saphenous Vein Aortocoronary Bypass Grafts J. Am. Coll. Cardiol., March 7, 2006; 47(5): 981 - 986. [Abstract] [Full Text] [PDF]

				J. Herrmann Peri-procedural myocardial injury: 2005 update Eur. Heart J., December 1, 2005; 26(23): 2493 - 2519. [Abstract] [Full Text] [PDF]

				M. Thielmann, P. Massoudy, A. Schmermund, M. Neuhauser, G. Marggraf, M. Kamler, U. Herold, I. Aleksic, K. Mann, M. Haude, et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery Eur. Heart J., November 2, 2005; 26(22): 2440 - 2447. [Abstract] [Full Text] [PDF]

				P Bahrmann, H R Figulla, M Wagner, M Ferrari, A Voss, and G S Werner Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions Heart, September 1, 2005; 91(9): 1186 - 1192. [Abstract] [Full Text] [PDF]

				G. A. Krombach, C. B. Higgins, M. Chujo, and M. Saeed Gadomer-enhanced MR Imaging in the Detection of Microvascular Obstruction: Alleviation with Nicorandil Therapy Radiology, August 1, 2005; 236(2): 510 - 518. [Abstract] [Full Text] [PDF]

				S R Dixon Infarct angioplasty: beyond stents and glycoprotein IIb/IIIa inhibitors Heart, June 1, 2005; 91(suppl_3): iii2 - iii6. [Full Text] [PDF]

				R. Schulz Pleiotropic effects of statins: Acutely good, but chronically bad? J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1292 - 1294. [Full Text] [PDF]

				A. Yamashita, E. Furukoji, K. Marutsuka, K. Hatakeyama, H. Yamamoto, S. Tamura, Y. Ikeda, A. Sumiyoshi, and Y. Asada Increased Vascular Wall Thrombogenicity Combined With Reduced Blood Flow Promotes Occlusive Thrombus Formation in Rabbit Femoral Artery Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2420 - 2424. [Abstract] [Full Text] [PDF]

				N. M. Malyar, L. O. Lerman, M. Gossl, P. E. Beighley, and E. L. Ritman Relation of Nonperfused Myocardial Volume and Surface Area to Left Ventricular Performance in Coronary Microembolization Circulation, October 5, 2004; 110(14): 1946 - 1952. [Abstract] [Full Text] [PDF]

				A. Skyschally, R. Schulz, P. Gres, I. Konietzka, C. Martin, M. Haude, R. Erbel, and G. Heusch Coronary microembolization does not induce acute preconditioning against infarction in pigs--the role of adenosine Cardiovasc Res, August 1, 2004; 63(2): 313 - 322. [Abstract] [Full Text] [PDF]

				M. Thielmann, P. Massoudy, G. Marggraf, S. Knipp, A. Schmermund, J. Piotrowski, R. Erbel, and H. Jakob Role of troponin I, myoglobin, and creatine kinase for the detection of early graft failure following coronary artery bypass grafting Eur. J. Cardiothorac. Surg., July 1, 2004; 26(1): 102 - 109. [Abstract] [Full Text] [PDF]

				A. Skyschally, M. Haude, H. Dorge, M. Thielmann, A. Duschin, A. van de Sand, I. Konietzka, A. Buchert, S. Aker, P. Massoudy, et al. Glucocorticoid Treatment Prevents Progressive Myocardial Dysfunction Resulting From Experimental Coronary Microembolization Circulation, May 18, 2004; 109(19): 2337 - 2342. [Abstract] [Full Text] [PDF]

				G. Heusch and K. R. Sipido Myocardial Hibernation: A Double-Edged Sword Circ. Res., April 30, 2004; 94(8): 1005 - 1007. [Full Text] [PDF]

				G Heusch and R Schulz Pathophysiology of coronary microembolisation Heart, September 1, 2003; 89(9): 981 - 982. [Full Text] [PDF]

				G. S. Werner, P. Bahrmann, O. Mutschke, U. Emig, S. Betge, M. Ferrari, and H. R. Figulla Determinants of target vessel failure in chronic total coronary occlusions after stent implantation: The influence of collateral function and coronary hemodynamics J. Am. Coll. Cardiol., July 16, 2003; 42(2): 219 - 225. [Abstract] [Full Text] [PDF]

				G. G. Neri Serneri, M. Boddi, P. A. Modesti, I. Cecioni, M. Coppo, M. L. Papa, T. Toscano, A. Marullo, and M. Chiavarelli Immunomediated and Ischemia-Independent Inflammation of Coronary Microvessels in Unstable Angina Circ. Res., June 27, 2003; 92(12): 1359 - 1366. [Abstract] [Full Text] [PDF]

				S. Mohlenkamp, P. E Beighley, E. A Pfeifer, T. R Behrenbeck, P. F Sheedy II, and E. L Ritman Intramyocardial blood volume, perfusion and transit time in response to embolization of different sized microvessels Cardiovasc Res, March 1, 2003; 57(3): 843 - 852. [Abstract] [Full Text] [PDF]

				L. Gregorini, J. Marco, B. Farah, M. Bernies, C. Palombo, M. Kozakova, I. M. Bossi, B. Cassagneau, J. Fajadet, C. Di Mario, et al. Effects of Selective {alpha}1- and {alpha}2-Adrenergic Blockade on Coronary Flow Reserve After Coronary Stenting Circulation, December 3, 2002; 106(23): 2901 - 2907. [Abstract] [Full Text] [PDF]

				K. Yamamoto, H. Ito, K. Iwakura, S. Kawano, M. Ikushima, T. Masuyama, T. Ogihara, and K. Fujii Two different coronary blood flow velocity patterns in thrombolysis in myocardial infarction flow grade 2 in acute myocardial infarction: Insight into mechanisms of microvascular dysfunction J. Am. Coll. Cardiol., November 20, 2002; 40(10): 1755 - 1760. [Abstract] [Full Text] [PDF]

				J. Herrmann, A. Lerman, D. Baumgart, L. Volbracht, R. Schulz, C. von Birgelen, M. Haude, G. Heusch, and R. Erbel Preprocedural Statin Medication Reduces the Extent of Periprocedural Non-Q-Wave Myocardial Infarction Circulation, October 22, 2002; 106(17): 2180 - 2183. [Abstract] [Full Text] [PDF]

				D. Nordhaug, T. Steensrud, C. Korvald, E. Aghajani, and T. Myrmel Preserved myocardial energetics in acute ischemic left ventricular failure - studies in an experimental pig model Eur. J. Cardiothorac. Surg., July 1, 2002; 22(1): 135 - 142. [Abstract] [Full Text] [PDF]

				N. Hedayati, J. T. Sherwood, S. J. Schomisch, J. L. Carino, and B. L. Cmolik Circulatory benefits of diastolic counterpulsation in an ischemic heart failure model after aortomyoplasty J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1067 - 1073. [Abstract] [Full Text] [PDF]

				J Herrmann, C von Birgelen, M Haude, L Volbracht, N Malyar, H Eggebrecht, T F M Konorza, D Baumgart, and R Erbel Prognostic implication of cardiac troponin T increase following stent implantation Heart, June 1, 2002; 87(6): 549 - 553. [Abstract] [Full Text] [PDF]

				M. Voskuil, R. A. M. van Liebergen, M. Albertal, E. Boersma, J. G. P. Tijssen, P. W. Serruys, J. J. Piek, and the DEBATE II Investigators Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty J. Am. Coll. Cardiol., May 1, 2002; 39(9): 1513 - 1517. [Abstract] [Full Text] [PDF]

				M. Thielmann, H. Dorge, C. Martin, S. Belosjorow, U. Schwanke, A. van de Sand, I. Konietzka, A. Buchert, A. Kruger, R. Schulz, et al. Myocardial Dysfunction With Coronary Microembolization: Signal Transduction Through a Sequence of Nitric Oxide, Tumor Necrosis Factor-{alpha}, and Sphingosine Circ. Res., April 19, 2002; 90(7): 807 - 813. [Abstract] [Full Text] [PDF]

				C. Loubeyre, M.-C. Morice, T. Lefevre, J.-F. Piechaud, Y. Louvard, and P. Dumas A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction J. Am. Coll. Cardiol., January 2, 2002; 39(1): 15 - 21. [Abstract] [Full Text] [PDF]

				K. Yamamoto, H. Ito, K. Iwakura, Y. Shintani, T. Masuyama, M. Hori, S. Kawano, Y. Higashino, and K. Fujii Pressure-derived collateral flow index as a parameter of microvascular dysfunction in acute myocardial infarction J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1383 - 1389. [Abstract] [Full Text] [PDF]

				J.J Piek, E Boersma, M Voskuil, C di Mario, E Schroeder, C Vrints, P Probst, B de Bruyne, C Hanet, E Fleck, et al. The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study Eur. Heart J., September 2, 2001; 22(18): 1725 - 1732. [Abstract] [PDF]

				J. Herrmann, M. Haude, A. Lerman, R. Schulz, L. Volbracht, J. Ge, A. Schmermund, H. Wieneke, C. von Birgelen, H. Eggebrecht, et al. Abnormal Coronary Flow Velocity Reserve After Coronary Intervention Is Associated With Cardiac Marker Elevation Circulation, May 15, 2001; 103(19): 2339 - 2345. [Abstract] [Full Text] [PDF]

				H. Dorge, T. Neumann, M. Behrends, A. Skyschally, R. Schulz, C. Kasper, R. Erbel, and G. Heusch Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2587 - H2592. [Abstract] [Full Text] [PDF]

				A. Skyschally, R. Schulz, R. Erbel, and G. Heusch Reduced coronary and inotropic reserves with coronary microembolization Am J Physiol Heart Circ Physiol, February 1, 2002; 282(2): H611 - H614. [Abstract] [Full Text] [PDF]

				M. Thielmann, H. Dorge, C. Martin, S. Belosjorow, U. Schwanke, A. van de Sand, I. Konietzka, A. Buchert, A. Kruger, R. Schulz, et al. Myocardial Dysfunction With Coronary Microembolization: Signal Transduction Through a Sequence of Nitric Oxide, Tumor Necrosis Factor-{alpha}, and Sphingosine Circ. Res., April 19, 2002; 90(7): 807 - 813. [Abstract] [Full Text] [PDF]

				M. Albertal, M. Voskuil, J.J. Piek, B. de Bruyne, G. Van Langenhove, P.I. Kay, M.A. Costa, E. Boersma, T. Beijsterveldt, J.E. Sousa, et al. Coronary Flow Velocity Reserve After Percutaneous Interventions Is Predictive of Periprocedural Outcome Circulation, April 2, 2002; 105(13): 1573 - 1578. [Abstract] [Full Text] [PDF]

This Article Figures Only Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this jou